Optic Pit Maculopathy: Clinical Features and Management Options

Author(s):  
Prashanth G. Iyer ◽  
Harry W. Flynn ◽  
Kenneth C. Fan ◽  
Audina M. Berrocal ◽  
Raquel Goldhardt
Author(s):  
Sean Duffy ◽  
Yael Gelfer ◽  
Alex Trompeter ◽  
Anna Clarke ◽  
Fergal Monsell

A correction to this paper has been published: https://doi.org/10.1007/s00590-021-02998-y


Author(s):  
Aaron E. Miller ◽  
Teresa M. DeAngelis

Lambert-Eaton myasthenia syndrome (LEMS) is an autoimmune-mediated disorder of the neuromuscular junction, which involves autoantibodies to voltage-gated calcium channels on the presynaptic membrane. In this chapter, we discuss the characteristic clinical features of LEMS, its electrophysiological distinction from MG, as well as its paraneoplastic presentation. We also review the immunotherapeutic management options in cases with severe weakness and those refractory to tumor removal.


2020 ◽  
Vol 9 (9) ◽  
pp. 2779
Author(s):  
Pawel Gasior ◽  
Aneta Desperak ◽  
Marek Gierlotka ◽  
Krzysztof Milewski ◽  
Krystian Wita ◽  
...  

Background: Diagnosis of myocardial infarction with non-obstructive coronary arteries (MINOCA) requires both clinical evidence of acute myocardial infarction (AMI) and demonstration of non-obstructive coronary arteries using angiography. We compared the clinical features, treatments, and three-year outcomes in patients with MINOCA and myocardial infarction with obstructive coronary artery disease (MI-CAD). Methods: We retrospectively analyzed data for 205,606 hospitalized patients with AMI. MINOCA was indicated as a working diagnosis in 6063 patients (2.94% of all AMI patients). For the control group we included 160,886 patients with MI-CAD. We evaluated the baseline characteristics, medication management options, outcomes, and readmission causes at 36 months follow-up. Results: Patients in the MINOCA group were younger. Females constituted a greater proportion of patients in the MINOCA group when compared to MI-CAD patients. STEMI during admission was diagnosed less frequently in the MINOCA group when compared to the MI-CAD group. All-cause mortality at 12 months was higher in the MINOCA group (10.94% vs. 9.54%, p < 0.001). At 36 months, there was no difference in the all-cause mortality rates (MINOCA 16.18% vs. MI-CAD 14.93%, p = 0.081). All-cause readmission rates were lower in the MINOCA group when compared to the MI-CAD group at both 12 months (45.19% vs. 54.33%, p < 0.001) and 36 months follow-up (56.42% vs. 66.66%, p < 0.001). Conclusions: This is the first description of the clinical features, treatments, and three-year outcomes in a large population of Polish patients. The main finding of this study was a relatively low rate of MINOCA, with high rates of adverse events both at 12 and 36 months follow-up.


2011 ◽  
Vol 251 (1) ◽  
pp. 381-382 ◽  
Author(s):  
Joaquín Marticorena ◽  
Francisco Gómez-Ulla ◽  
Mario R. Romano ◽  
Maribel Fernández

2007 ◽  
Vol 27 (5) ◽  
pp. 293-297 ◽  
Author(s):  
Serra Arf Karacorlu ◽  
Murat Karacorlu ◽  
Hakan Ozdemir ◽  
Engin Burumcek ◽  
Haluk Esgin

Retina ◽  
2013 ◽  
Vol 33 (4) ◽  
pp. 771-775 ◽  
Author(s):  
Rupak Roy ◽  
Anton D. Waanbah ◽  
Gaurav Mathur ◽  
Rajiv Raman ◽  
Tarun Sharma

Retina ◽  
2006 ◽  
Vol 26 (1) ◽  
pp. 113-116 ◽  
Author(s):  
SUK J. MOON ◽  
JUDY E. KIM ◽  
RICHARD F. SPAIDE

Sign in / Sign up

Export Citation Format

Share Document